Company profile · Onderzoeks- & kennisinstelling
Exomnis Biotech
- Biotechnology
- Onderzoeks- & kennisinstelling
- Maastricht
- Biotechnology · Maastricht
- Employees
- 2–10
- Founded
- 2013
- Province
- Limburg
- Country
- Netherlands
About Exomnis Biotech
Exomnis Biotech is a Maastricht based start-up company, operating at the intersection of microbiology, engineering and immunology. As a spin-off from Maastricht University, taking advantage of more than 100 years combined experience, we have developed engineered commensal bacteria as “living medicines” with a first focus on immuno-therapeutics for cancer treatments.
Our solution employs forefront synthetic biology techniques to genetically engineer anaerobic, spore-forming bacteria (Clostridium Sporogenes) with CRISPR-Cas9 gene editing and allelic exchange technology. These plasmid and antibiotic-free spores become delivery vehicles that secret therpautics only at the core of hypoxic/necrotic tumours.
Keywords
- Clostridium Sporogenes
- Immunotherapy
- Pharma Contract Service
- Smart Bacteria Based Drug Delivery System
- Viral Infection Vaccination Delivery
Address
Headquarters
Oxfordlaan 556229EV MaastrichtLimburg, Netherlands
Team by function
Based on 1 public job profiles as of 3 September 2026.
- Research / R&D1
Similar companies
Companies with a similar profile, Limburg first.
ToxGenSolutions BV TGS
Biotechnology · Maastricht
11–50 employeesView profile

Innexo BV
Research · Horst
2–10 employeesView profile

PathoNostics
Medical Devices · Maastricht
11–50 employeesView profile

Excytex
Research · Utrecht
2–10 employeesView profile

Omnigen BV
Biotechnology · Delft
2–10 employeesView profile

Microbial Analysis
Biotechnology · Groningen
2–10 employeesView profile